|
|
|
 |
Alun is President and Chief Scientific Officer of PharmacoGenomic Innovative Solutions and has over 20 years experience
in the pharmaceutical industry. This includes drug discovery, biomarker and imaging applications,
clinical development and product communications.
He has extensive experience of pharmacogenomics including design, implementation and interpretation of disease- & pharmaco-genetics studies as part of drug discovery & development, ethical issues relevant to (pharmaco)genetic research and clinical practice, impact of
pharmacogenetics on regulatory aspects of drug development and registration, cross-industry groups addressing non-competitive issues impacting adoption of pharmacogenetics.
|
|
|
|
Who We Are